Researchers from KAIST, UC Berkeley, and Gladstone Institutes have developed a CRISPR-based diagnostic that distinguishes multiple viruses and variants simultaneously by analyzing the reaction speed ...
A stabilized mRNA carrier turns tumor injection into broader immune activation by extending vaccine delivery to lymph nodes ...
Filipino tennis ace Alex Eala is putting in the work on clay as she prepares for her next major test on tour, the Italian ...
Company secures $5M in funding to accelerate its rapid testing platformUSP<1223> Validation achieved, reinforcing 20-hour testing ...
A new study analyzed piRNA — first discovered in 2006 — as a strong predictor of short-term survival in older patients. It ...
The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Understanding the source of stress and disease can be difficult, especially if the subject of stress is a fish or even thousands of fish.
Effect of digital Ki67-based risk modeling on prognostic precision in non–muscle-invasive bladder cancer and high-risk subsets in mixed-grade tumors. Prospective multicenter development and external ...
CLEVELAND — For families battling ultra-rare diseases, a new framework from the U.S. Food and Drug Administration could mean faster access to potentially life-saving treatments. The FDA has issued ...
The Department of Health and Human Services, Office of Inspector General (“OIG”) recently released a favorable advisory opinion, OIG Advisory Opinion No. 26‑01 (“AO 26‑01” or the “Opinion”) addressing ...
Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results